These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39002870)

  • 21. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance.
    Chandra Jena B; Sarkar S; Rout L; Mandal M
    Cancer Lett; 2021 Nov; 520():222-232. PubMed ID: 34363903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies.
    Liu Q; Yao F; Wu L; Xu T; Na J; Shen Z; Liu X; Shi W; Zhao Y; Liao Y
    Clin Transl Oncol; 2024 Oct; 26(10):2395-2417. PubMed ID: 38602644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of being CAFs (in cancer resistance to targeted therapies).
    Rizzolio S; Giordano S; Corso S
    J Exp Clin Cancer Res; 2022 Nov; 41(1):319. PubMed ID: 36324182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting CAFs to overcome anticancer therapeutic resistance.
    Saw PE; Chen J; Song E
    Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets.
    Lappano R; Rigiracciolo DC; Belfiore A; Maggiolini M; De Francesco EM
    Expert Opin Ther Targets; 2020 Jun; 24(6):559-572. PubMed ID: 32249708
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional diversity of cancer-associated fibroblasts in modulating drug resistance.
    Bu L; Baba H; Yasuda T; Uchihara T; Ishimoto T
    Cancer Sci; 2020 Oct; 111(10):3468-3477. PubMed ID: 33044028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
    Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
    J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast.
    Ochi K; Suzawa K; Thu YM; Takatsu F; Tsudaka S; Zhu Y; Nakata K; Takeda T; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Shien T; Okamoto Y; Tomida S; Toyooka S
    Cancer Sci; 2022 Oct; 113(10):3428-3436. PubMed ID: 35871750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer.
    Feng H; Cao B; Peng X; Wei Q
    BMC Cancer; 2022 Jul; 22(1):764. PubMed ID: 35831824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Directions for Advanced Targeting Strategies of EGFR Signaling in Cancer.
    Zhou Y; Takahashi JI; Sakurai H
    Biol Pharm Bull; 2024; 47(5):895-903. PubMed ID: 38692865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAG3 in Tumor Resistance to Therapy.
    De Marco M; Turco MC; Marzullo L
    Trends Cancer; 2020 Dec; 6(12):985-988. PubMed ID: 32718905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
    Guo J; Zeng H; Chen Y
    Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.
    Sato H; Noma K; Ohara T; Kawasaki K; Akai M; Kobayashi T; Nishiwaki N; Narusaka T; Komoto S; Kashima H; Katsura Y; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Sci Rep; 2022 Nov; 12(1):20152. PubMed ID: 36418422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
    Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
    Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.